Stop hidingfrom your moderate-to-severe eczema
The ADVISE Study is evaluating the safety and effectiveness of an investigational medication, taken orally, designed for moderate-to-severe eczema.
Let’s work together to find a potential new treatment for this frustrating condition.
You may be able to take part in the ADVISE Study if:
You will receive all study-related care at no cost. Health insurance is not needed.
Eczema is a term used to describe medical conditions that cause red, inflamed, and itchy skin.
adults have some form of moderate-to-severe atopic dermatitis in the United States.
It is more common in females than males
The most common form of eczema, atopic dermatitis, is caused by a malfunction in the immune system
The annual economic burden of moderate-to-severe eczema in the United States is estimated at $5.3 billion
In order to improve the quality of life in those with moderate-to-severe eczema, more research is sorely needed.